Patents by Inventor Greg Fontenot

Greg Fontenot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Trans-Clomiphene and Progesterone Receptor Antagonist Combination Therapy for Treating Hormone-Dependent Conditions
    Publication number: 20190008804
    Abstract: The present invention pertains to a combination for simultaneous, separate, or sequential use which comprises (a) trans-clomiphene or a salt or analogue thereof and (b) a progesterone receptor antagonist and to its use for the treatment of hormone-dependent conditions.
    Type: Application
    Filed: January 11, 2017
    Publication date: January 10, 2019
    Inventors: Joseph S. Podolski, Greg Fontenot
  • Trans-clomiphene for use in cancer therapy
    Patent number: 9687458
    Abstract: The present invention relates to the administration of compositions comprising an antiestrogen, preferably a selective estrogen receptor modulator (SERM) such as trans-clomiphene, for treating cancer and associated diseases. The invention is also directed to methods for reducing IGF-1 levels in a subject in need thereof by administering a composition comprising an antiestrogen, preferably a SERM such as trans-clomiphene.
    Type: Grant
    Filed: October 22, 2013
    Date of Patent: June 27, 2017
    Assignee: Repros Therapeutics Inc.
    Inventors: Joseph S. Podolski, Ronald D. Wiehle, Kuang Hsu, Greg Fontenot
  • Trans-clomiphene and its analogues as agents that increase bone mineral density
    Patent number: 9616034
    Abstract: The present invention relates to the administration of compositions comprising trans-clomiphene or an analog or salt thereof, for inhibiting bone resorption and bone turnover in a subject. The invention is also directed to methods for increasing bone mineral density in a subject and preventing or treating a bone related disorder in a subject comprising administering to the subject an effective amount of trans-clomiphene or an analog or salt thereof.
    Type: Grant
    Filed: June 3, 2014
    Date of Patent: April 11, 2017
    Assignee: REPROS THERAPEUTICS INC.
    Inventors: Joseph S. Podolski, Kuang Hsu, Ronald D. Wiehle, Greg Fontenot, Jaye Thompson
  • TRANS-CLOMIPHENE AND ITS ANALOGUES AS AGENTS THAT INCREASE BONE MINERAL DENSITY
    Publication number: 20160128953
    Abstract: The present invention relates to the administration of compositions comprising trans-clomiphene or an analogue or salt thereof, for inhibiting bone resorption and bone turnover in a subject. The invention is also directed to methods for increasing bone mineral density in a subject and preventing or treating a bone related disorder in a subject comprising administering to the subject an effective amount of trans-clomiphene or an analogue or salt thereof.
    Type: Application
    Filed: June 3, 2014
    Publication date: May 12, 2016
    Applicant: REPROS THERAPEUTICS INC.
    Inventors: Joseph S. PODOLSKI, Kuang HSU, Ronald D. WIEHLE, Greg FONTENOT, Jaye THOMPSON
  • Trans-Clomiphene for Use in Cancer Therapy
    Publication number: 20150283099
    Abstract: The present invention relates to the administration of compositions comprising an antiestrogen, preferably a selective estrogen receptor modulator (SERM) such as trans-clomiphene, for treating cancer and associated diseases. The invention is also directed to methods for reducing IGF-1 levels in a subject in need thereof by administering a composition comprising an antiestrogen, preferably a SERM such as trans-clomiphene.
    Type: Application
    Filed: October 22, 2013
    Publication date: October 8, 2015
    Applicant: REPROS THERAPEUTICS INC.
    Inventors: Joseph S. Podolski, Ronald D. Wiehle, Kuang Hsu, Greg Fontenot